Testicular Microlithiasis |
| Testicular
microlithiasis (TM) is an ultrasonographic finding characterized by
scattered calcium deposits within the seminiferous tubules. It appears
as punctate, hyperechogenic foci, typically no larger than 1 to 3 mm,
that do not produce posterior acoustic shadowing, a feature that
distinguishes it from other testicular calcifications with different
clinical significance. Its characteristic appearance, sometimes
described as a "snowstorm" pattern, is usually identified incidentally
during scrotal ultrasound performed for unrelated reasons, since the
condition is painless and impalpable on physical examination. Since its
first radiological description in a four-year-old boy in the early
1970s, and its later characterization by ultrasound years afterward,
clinical interest in TM has steadily grown, driven largely by the
uncertainty surrounding its possible association with testicular
malignancy. Histologically, TM is defined by the presence of laminated calcifications within the seminiferous tubule—rounded bodies made up of concentric rings that, according to the most widely accepted hypotheses, originate from the inability of Sertoli cells to fully phagocytose degenerated germ cell debris. This unremoved cellular material is thought to act as a nidus onto which glycoproteins and calcium salts progressively deposit, eventually forming the microcalcospherites visible on pathology. Other hypotheses point to local disturbances in mineral metabolism, genetic factors, or hormonal imbalances that impair androgen stimulation of Sertoli cells. None of these explanations is considered definitive, and the fact that laminated calcifications can also be found in histologically normal testes—as well as in cryptorchid testes or those harboring germ cell tumors—complicates the interpretation of their exact origin. Radiologically, the diagnosis is established when five or more hyperechogenic foci are identified in a single ultrasound image, defining classic TM; below that threshold, the finding is termed limited TM. Distribution may be diffuse or focal, and involvement can be unilateral or bilateral, although in the pediatric population bilateral involvement and the classic pattern consistently predominate. This classification, while descriptively useful, does not substantially change follow-up recommendations, since current guidelines do not differentiate management based on subtype. The prevalence of TM in children varies widely depending on the population studied, the diagnostic definition used, and the frequency of the transducer employed. Taken together, pediatric studies place the prevalence at approximately 2% in symptomatic children referred for ultrasound and somewhat above 4% in asymptomatic children, with a tendency to increase with age and with more recent publication dates, likely reflecting the greater resolution of current ultrasound equipment. These figures are roughly comparable to those reported in asymptomatic young adults. TM is more frequently associated with certain benign conditions, such as undescended testis—where its prevalence can range from about 3% to 12%—a history of orchidopexy, varicocele, and hypospadias. A markedly elevated prevalence has also been described in children with Down syndrome, Klinefelter syndrome, and, particularly strikingly, McCune-Albright syndrome, where some series report figures above 20% and even close to 60%. Whether these associations reflect a genuine causal relationship or simply the fact that these patients are more likely to undergo repeated ultrasound studies remains unknown. The most debated aspect of TM continues to be its relationship with testicular germ cell tumors. In adults, several systematic reviews have found an increased relative risk of testicular neoplasia in the presence of TM, particularly in subgroups with additional risk factors such as cryptorchidism, subfertility, or a personal history of testicular tumor; in contrast, asymptomatic patients without risk factors show no such increase. In the pediatric population, the picture is less clear. Large follow-up series agree that the vast majority of children with TM remain free of neoplasia during the observation period, with new tumor rates below 1% in most cohorts, although at least one large multicenter study has reported testicular tumor rates several times higher in children with TM compared with those without it, keeping the controversy open. One factor that complicates interpretation of these findings is the short duration of follow-up in most pediatric studies—usually between six months and a few years—which rarely extends beyond puberty, the point at which the incidence of germ cell tumors naturally begins to rise. In other words, a substantial part of the relevant risk window simply has not yet been observed in the children included in these studies. When tumors have been reported concurrently with TM in prepubertal children, most are benign or premalignant lesions, and they are frequently associated with identifiable risk factors such as cryptorchidism or predisposing genetic syndromes. Frankly malignant tumors are far more common in adolescents older than thirteen years, an age at which the risk profile begins to approach that of young adults. Furthermore, the course of TM itself during childhood appears largely stable: in series with repeated ultrasound follow-up, only a minority of testes show a significant increase in microlith count, and a non-negligible proportion show a reduction or even complete resolution of the finding over time. No studies have been specifically designed to assess whether TM diagnosed before puberty is associated with infertility in adulthood, a gap that recent reviews highlight as a priority for future research. Given this uncertainty, both European and American societies agree on one central point: isolated TM, without additional risk factors, does not require systematic ultrasound follow-up or routine serum tumor marker testing—measures that have not been shown to change outcomes and that, conversely, may generate unwarranted anxiety for the patient and family, along with unnecessary cost and exposure. Differences emerge when additional risk factors are present—cryptorchidism, testicular atrophy, a personal or family history of testicular tumor, or predisposing genetic syndromes. European bodies tend to recommend periodic, generally annual, ultrasound surveillance along with education on self-examination from puberty onward; American guidelines instead prioritize education and monthly self-examination, reserving ultrasound for suspicious clinical findings, without establishing a formal imaging surveillance program. Both frameworks emphasize the importance of prompt ultrasound access when self-examination detects a change, as well as the need to plan the transition of pediatric patients with TM and risk factors to adult urology care upon reaching the age of majority, since it is precisely in that later stage that the risk of malignancy appears to become more clearly established. Taken together, current evidence repositions childhood testicular microlithiasis as a generally benign and often transient finding, rather than a reliable marker of imminent oncologic risk. Its management should be individualized according to clinical context: reassurance and education in isolated cases, and closer—though not excessive—clinical surveillance in children who also present recognized risk factors. Fundamental questions remain unresolved, including whether TM detected in childhood represents the same biological entity observed in adults, what its true impact on future fertility might be, and whether extended follow-up beyond puberty would change current conclusions about malignancy risk. Answering these questions will require prospective, multicenter studies with follow-up extending into adulthood, something the literature available to date still lacks. References: 1- Yu CJ, Lu JD, Zhao J, Wei Y, Zhao TX, Lin T, He DW, Wu SD, Wei GH. Incidence characteristics of testicular microlithiasis and its association with risk of primary testicular tumors in children: a systematic review and meta-analysis. World J Pediatr. 16(6):585-597, 2020 2- Hoen LA, Bhatt NR, Radmayr C, Dogan HS, Nijman RJM, Quaedackers J, Rawashdeh YF, Silay MS, Tekgul S, Stein R, Bogaert G. The prognostic value of testicular microlithiasis as an incidental finding for the risk of testicular malignancy in children and the adult population: A systematic review. On behalf of the EAU pediatric urology guidelines panel. J Pediatr Urol. 17(6):815-831, 2021 3- Sag S, Elemen L, Masrabaci K, Gungormez EK. Is testicular microlithiasis associated with testicular pathologies in children? Pediatr Surg Int. 38(9):1317-1319, 2022 4- Flores HA, Bailey WC, Harris KT. Management of pediatric testicular microlithiasis. Front Pediatr. 13:1588261, 2025 5- Zitouni H, Dghaies R, Kechiche N, Mhiri R. Pediatric testicular microlithiasis: a review of epidemiology, risk associations and management. Front Pediatr. 13:1553825, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|